Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Pneumonia III: Complications and Assessment

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:

Atypical Pneumonia

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...

Pneumonia I: Introduction

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...

Pneumonia I: Introduction

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...

Special Staining Techniques

Special Staining Techniques

Specialized staining techniques play a vital role in microbiology by enabling the visualization of specific bacterial structures that remain undetectable with standard microscopy methods. These techniques not only enhance the structural visualization of bacterial cells but also provide critical insights into their pathogenicity and classification. Additionally, they support diagnostic and research endeavors in microbiology by identifying key bacterial features.Capsule Staining for Virulence...

Bacterial Meningitis II: Pathophysiology

Bacterial Meningitis II: Pathophysiology

Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

The Protective or Curative Element in Type B H. influenzae Rabbit Serum.

The Yale journal of biology and medicine·2011

Same author

Antibody formation in the immunization of human beings.

Federation proceedings·2010

Same author

Spectrophotometric standardization of complement for fixation tests.

Journal of immunology (Baltimore, Md. : 1950)·2010

Same author

Studies in human malaria; attempts to influence relapsing vivax malaria by treatment of patients with vaccine (Pl. vivax).

Journal of immunology (Baltimore, Md. : 1950)·2010

Same author

Studies in human malaria; an attempt at vaccination of paretics against blood-borne infection with Pl. vivax.

Journal of immunology (Baltimore, Md. : 1950)·2010

Same author

Studies in human malaria; an attempt at vaccination of volunteers against mosquito-borne infection with Pl. vivax.

Journal of immunology (Baltimore, Md. : 1950)·2010

Search research articles

Related Experiment Video

Updated: Jun 19, 2026

Investigating the Effects of Probiotics on Pneumococcal Colonization Using an In Vitro Adherence Assay

Investigating the Effects of Probiotics on Pneumococcal Colonization Using an In Vitro Adherence Assay

Published on: April 28, 2014

THE SOLUBLE SPECIFIC SUBSTANCE OF PNEUMOCOCCUS : THIRD PAPER.

M Heidelberger¹, W F Goebel, O T Avery

¹Hospital of The Rockefeller Institute for Medical Research.

The Journal of Experimental Medicine

|October 30, 2009

Summary

Researchers refined methods to isolate pneumococcus soluble specific substances (SSS). These SSS, particularly from Types II and III, are nitrogen-free, highly active, and distinct for each pneumococcus type, confirming their role as specific substances.

More Related Videos

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

Opsonophagocytic Killing Assay to Assess Immunological Responses Against Bacterial Pathogens

Opsonophagocytic Killing Assay to Assess Immunological Responses Against Bacterial Pathogens

Published on: April 5, 2019

Related Experiment Videos

Last Updated: Jun 19, 2026

Investigating the Effects of Probiotics on Pneumococcal Colonization Using an In Vitro Adherence Assay

Investigating the Effects of Probiotics on Pneumococcal Colonization Using an In Vitro Adherence Assay

Published on: April 28, 2014

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

Opsonophagocytic Killing Assay to Assess Immunological Responses Against Bacterial Pathogens

Opsonophagocytic Killing Assay to Assess Immunological Responses Against Bacterial Pathogens

Published on: April 5, 2019

Area of Science:

Microbiology
Immunochemistry
Biochemistry

Background:

Pneumococcus infections are a significant public health concern.
Understanding the specific substances of pneumococcus is crucial for developing effective treatments and vaccines.
Previous methods for isolating these substances were limited in purity and activity.

Purpose of the Study:

To refine isolation methods for soluble specific substances (SSS) of Types II and III pneumococcus.
To characterize the SSS of Type I pneumococcus and compare it with Types II and III.
To identify the constituent sugar units of pneumococcal polysaccharides.

Main Methods:

Improved chemical isolation techniques for pneumococcal SSS.
Characterization of SSS purity, nitrogen content, and activity with immune serum.
Comparative analysis of SSS from different pneumococcus types.
Sugar unit identification within isolated polysaccharides.

Main Results:

Refined methods yielded nitrogen-free SSS of Types II and III with enhanced activity.
Type I SSS was isolated and shown to be distinctly different from Types II and III SSS.
Significant differences were observed between the SSS of all three pneumococcus types.
Progress was made in identifying the specific sugar units composing these polysaccharides.

Conclusions:

The isolated polysaccharides are confirmed as the actual specific substances of pneumococcus.
The distinct chemical nature of SSS among different pneumococcus types provides a basis for type-specific immunity.
Further research into the sugar composition can inform vaccine development and therapeutic strategies.